Critical role of constitutive type i interferon response in bronchial epithelial cell to influenza infection

PLoS ONE

Volumn 7, Issue 3, 2012, Pages

  Hsu, Alan C Y ^a   Parsons, Kristy ^a   Barr, Ian ^b   Lowther, Sue ^c   Middleton, Deborah ^c   Hansbro, Philip M ^a   Wark, Peter A B ^a,d  

^a UNIVERSITY OF NEWCASTLE   (Australia)

^b WORLD HEALTH ORGANIZATION   (Switzerland)

^c CSIRO   (Australia)

^d JOHN HUNTER HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

BETA INTERFERON; GLYCOPROTEIN; INTERFERON; INTERFERON RECEPTOR; RETINOIC ACID INDUCIBLE PROTEIN I; SIALIC ACID; CYCLOHEXIMIDE; N ACETYLNEURAMINIC ACID; PROTEIN SYNTHESIS INHIBITOR;

APOPTOSIS; ARTICLE; BRONCHUS MUCOSA; CELL STIMULATION; CONTROLLED STUDY; CYTOKINE RESPONSE; ENDOCYTOSIS; EPITHELIUM CELL; HUMAN; HUMAN CELL; INFECTION SENSITIVITY; INFLUENZA; INFLUENZA A (H3N2); INFLUENZA A (H5N1); INNATE IMMUNITY; INTERFERON INDUCTION; INTERFERON PRODUCTION; SIGNAL TRANSDUCTION; VIRUS CELL INTERACTION; VIRUS REPLICATION; ANIMAL; BIOLOGICAL MODEL; BRONCHUS; CELL LINE; CHEMISTRY; CYTOLOGY; DOG; INFLUENZA VIRUS A H3N2; INFLUENZA VIRUS A H5N1; METABOLISM; VIROLOGY;

ORTHOMYXOVIRIDAE;

ANIMALS; APOPTOSIS; BRONCHI; CELL LINE; CYCLOHEXIMIDE; DOGS; EPITHELIAL CELLS; HUMANS; INFLUENZA A VIRUS, H3N2 SUBTYPE; INFLUENZA A VIRUS, H5N1 SUBTYPE; INFLUENZA, HUMAN; INTERFERON TYPE I; INTERFERON-BETA; MODELS, BIOLOGICAL; N-ACETYLNEURAMINIC ACID; PROTEIN SYNTHESIS INHIBITORS;

EID: 84857735166     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0032947     Document Type: Article

References (69)

1. Fraser C, Donnelly CA, Cauchemez S, Hanage WP, Van Kerkhove MD, et al. (2009) Pandemic Potential of a Strain of Influenza A (H1N1): Early Findings. Science.
2. Ito T, Suzuki Y, Suzuki T, Takada A, Horimoto T, et al. (2000) Recognition of N-glycolylneuraminic acid linked to galactose by the alpha2,3 linkage is associated with intestinal replication of influenza A virus in ducks. J Virol 74: 9300-9305.
3. Ito T, Suzuki Y, Takada A, Kawamoto A, Otsuki K, et al. (1997) Differences in sialic acid-galactose linkages in the chicken egg amnion and allantois influence human influenza virus receptor specificity and variant selection. J Virol 71: 3357-3362.
4. Ryan-Poirier K, Suzuki Y, Bean WJ, Kobasa D, Takada A, et al. (1998) Changes in H3 influenza A virus receptor specificity during replication in humans. Virus Res 56: 169-176.
5. Suzuki Y, (1998) [Influenza viruses and their receptor sugar recognition]. Tanpakushitsu Kakusan Koso 43: 2559-2566.
6. Durbin JE, Fernandez-Sesma A, Lee CK, Rao TD, Frey AB, et al. (2000) Type I IFN modulates innate and specific antiviral immunity. J Immunol 164: 4220-4228.
7. Sheppard P, Kindsvogel W, Xu W, Henderson K, Schlutsmeyer S, et al. (2003) IL-28, IL-29 and their class II cytokine receptor IL-28R. Nat Immunol 4: 63-68.
8. Fitzgerald KA, McWhirter SM, Faia KL, Rowe DC, Latz E, et al. (2003) IKKepsilon and TBK1 are essential components of the IRF3 signaling pathway. Nat Immunol 4: 491-496.
9. Sharma S, tenOever BR, Grandvaux N, Zhou GP, Lin R, et al. (2003) Triggering the interferon antiviral response through an IKK-related pathway. Science 300: 1148-1151.
10. Kotenko SV, Gallagher G, Baurin VV, Lewis-Antes A, Shen M, et al. (2003) IFN-lambdas mediate antiviral protection through a distinct class II cytokine receptor complex. Nat Immunol 4: 69-77.
11. Levy DE, Darnell JE Jr, (2002) Stats: transcriptional control and biological impact. Nat Rev Mol Cell Biol 3: 651-662.
12. Garcia MA, Gil J, Ventoso I, Guerra S, Domingo E, et al. (2006) Impact of protein kinase PKR in cell biology: from antiviral to antiproliferative action. Microbiol Mol Biol Rev 70: 1032-1060.
13. Gil J, Esteban M, (2000) Induction of apoptosis by the dsRNA-dependent protein kinase (PKR): mechanism of action. Apoptosis 5: 107-114.
14. Zhang P, Samuel CE, (2007) Protein kinase PKR plays a stimulus- and virus-dependent role in apoptotic death and virus multiplication in human cells. J Virol 81: 8192-8200.
15. Stark GR, Kerr IM, Williams BR, Silverman RH, Schreiber RD, (1998) How cells respond to interferons. Annu Rev Biochem 67: 227-264.
16. Chen Z, Li Y, Krug RM, (1999) Influenza A virus NS1 protein targets poly(A)-binding protein II of the cellular 3′-end processing machinery. Embo J 18: 2273-2283.
17. Opitz B, Rejaibi A, Dauber B, Eckhard J, Vinzing M, et al. (2007) IFNbeta induction by influenza A virus is mediated by RIG-I which is regulated by the viral NS1 protein. Cell Microbiol 9: 930-938.
18. Siren J, Imaizumi T, Sarkar D, Pietila T, Noah DL, et al. (2006) Retinoic acid inducible gene-I and mda-5 are involved in influenza A virus-induced expression of antiviral cytokines. Microbes Infect 8: 2013-2020.
19. Shapira SD, Gat-Viks I, Shum BO, Dricot A, de Grace MM, et al. (2009) A physical and regulatory map of host-influenza interactions reveals pathways in H1N1 infection. Cell 139: 1255-1267.
20. Jewell NA, Cline T, Mertz SE, Smirnov SV, Flano E, et al. (2010) Interferon-{lambda} is the predominant interferon induced by influenza A virus infection in vivo. J Virol 84: 11515-11522.
21. Kumagai Y, Takeuchi O, Kato H, Kumar H, Matsui K, et al. (2007) Alveolar macrophages are the primary interferon-alpha producer in pulmonary infection with RNA viruses. Immunity 27: 240-252.
22. Gao Y, Zhang Y, Shinya K, Deng G, Jiang Y, et al. (2009) Identification of amino acids in HA and PB2 critical for the transmission of H5N1 avian influenza viruses in a mammalian host. PLoS Pathog 5: e1000709.
23. Lam WY, Tang JW, Yeung AC, Chiu LC, Sung JJ, et al. (2008) Avian influenza virus A/HK/483/97(H5N1) NS1 protein induces apoptosis in human airway epithelial cells. J Virol 82: 2741-2751.
24. Ranjan P, Jayashankar L, Deyde V, Zeng H, Davis WG, et al. (2010) 5′PPP-RNA induced RIG-I activation inhibits drug-resistant avian H5N1 as well as 1918 and 2009 pandemic influenza virus replication. Virol J 7: 102.
25. Twu KY, Kuo RL, Marklund J, Krug RM, (2007) The H5N1 influenza virus NS genes selected after 1998 enhance virus replication in mammalian cells. J Virol 81: 8112-8121.
26. Hsu AC, Barr I, Hansbro PM, Wark PA, (2010) Human Influenza is More Effective than Avian Influenza at Antiviral Suppression in Airway Cells. Am J Respir Cell Mol Biol.
27. Bornholdt ZA, Prasad BV, (2008) X-ray structure of NS1 from a highly pathogenic H5N1 influenza virus. Nature.
28. Jackson D, Hossain MJ, Hickman D, Perez DR, Lamb RA, (2008) A new influenza virus virulence determinant: the NS1 protein four C-terminal residues modulate pathogenicity. Proc Natl Acad Sci U S A 105: 4381-4386.
29. Jiao P, Tian G, Li Y, Deng G, Jiang Y, et al. (2008) A single-amino-acid substitution in the NS1 protein changes the pathogenicity of H5N1 avian influenza viruses in mice. J Virol 82: 1146-1154.
30. Chawla-Sarkar M, Lindner DJ, Liu YF, Williams BR, Sen GC, et al. (2003) Apoptosis and interferons: role of interferon-stimulated genes as mediators of apoptosis. Apoptosis 8: 237-249.
31. Clemens MJ, (2003) Interferons and apoptosis. J Interferon Cytokine Res 23: 277-292.
32. Saedisomeolia A, Wood LG, Garg ML, Gibson PG, Wark PA, (2009) Anti-inflammatory effects of long-chain n-3 PUFA in rhinovirus-infected cultured airway epithelial cells. The British journal of nutrition 101: 533-540.
33. Lopez-Souza N, Dolganov G, Dubin R, Sachs LA, Sassina L, et al. (2004) Resistance of differentiated human airway epithelium to infection by rhinovirus. American journal of physiology Lung cellular and molecular physiology 286: L373-381.
34. Wark PA, Bucchieri F, Johnston SL, Gibson PG, Hamilton L, et al. (2007) IFN-gamma-induced protein 10 is a novel biomarker of rhinovirus-induced asthma exacerbations. The Journal of allergy and clinical immunology 120: 586-593.
35. Wark PA, Johnston SL, Bucchieri F, Powell R, Puddicombe S, et al. (2005) Asthmatic bronchial epithelial cells have a deficient innate immune response to infection with rhinovirus. J Exp Med 201: 937-947.
36. Hsu AC, Barr I, Hansbro PM, Wark PA, (2011) Human influenza is more effective than avian influenza at antiviral suppression in airway cells. American Journal of Respiratory Cell and Molecular Biology 44: 906-913.
37. Hausmann S, Marq JB, Tapparel C, Kolakofsky D, Garcin D, (2008) RIG-I and dsRNA-induced IFNbeta activation. PLoS ONE 3: e3965.
38. Hornung V, Ellegast J, Kim S, Brzozka K, Jung A, et al. (2006) 5′-Triphosphate RNA is the ligand for RIG-I. Science 314: 994-997.
39. Kato H, Takeuchi O, Sato S, Yoneyama M, Yamamoto M, et al. (2006) Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses. Nature 441: 101-105.
40. Loo YM, Fornek J, Crochet N, Bajwa G, Perwitasari O, et al. (2008) Distinct RIG-I and MDA5 signaling by RNA viruses in innate immunity. J Virol 82: 335-345.
41. Matsukura S, Kokubu F, Kurokawa M, Kawaguchi M, Ieki K, et al. (2007) Role of RIG-I, MDA-5, and PKR on the expression of inflammatory chemokines induced by synthetic dsRNA in airway epithelial cells. Int Arch Allergy Immunol 143 (Suppl 1): 80-83.
42. Takeuchi O, Akira S, (2008) MDA5/RIG-I and virus recognition. Curr Opin Immunol 20: 17-22.
43. Guo Z, Chen LM, Zeng H, Gomez JA, Plowden J, et al. (2007) NS1 protein of influenza A virus inhibits the function of intracytoplasmic pathogen sensor, RIG-I. Am J Respir Cell Mol Biol 36: 263-269.
44. Collins SE, Noyce RS, Mossman KL, (2004) Innate cellular response to virus particle entry requires IRF3 but not virus replication. J Virol 78: 1706-1717.
45. Gack MU, Albrecht RA, Urano T, Inn KS, Huang IC, et al. (2009) Influenza A virus NS1 targets the ubiquitin ligase TRIM25 to evade recognition by the host viral RNA sensor RIG-I. Cell Host Microbe 5: 439-449.
46. Ludwig S, Wang X, Ehrhardt C, Zheng H, Donelan N, et al. (2002) The influenza A virus NS1 protein inhibits activation of Jun N-terminal kinase and AP-1 transcription factors. J Virol 76: 11166-11171.
47. Talon J, Horvath CM, Polley R, Basler CF, Muster T, et al. (2000) Activation of interferon regulatory factor 3 is inhibited by the influenza A virus NS1 protein. J Virol 74: 7989-7996.
48. Wang X, Li M, Zheng H, Muster T, Palese P, et al. (2000) Influenza A virus NS1 protein prevents activation of NF-kappaB and induction of alpha/beta interferon. J Virol 74: 11566-11573.
49. Qiu Y, Krug RM, (1994) The influenza virus NS1 protein is a poly(A)-binding protein that inhibits nuclear export of mRNAs containing poly(A). J Virol 68: 2425-2432.
50. Ralser M, Wamelink MM, Kowald A, Gerisch B, Heeren G, et al. (2007) Dynamic rerouting of the carbohydrate flux is key to counteracting oxidative stress. Journal of biology 6: 10.
51. Phipps-Yonas H, Seto J, Sealfon SC, Moran TM, Fernandez-Sesma A, (2008) Interferon-beta pretreatment of conventional and plasmacytoid human dendritic cells enhances their activation by influenza virus. PLoS Pathog 4: e1000193.
52. Gale M Jr, Tan S-L, Katze MG, (2000) Translational Control of Viral Gene Expression in Eukaryotes. Microbiol Mol Biol Rev 64: 239-280.
53. Alessenko AV, Boikov P, Filippova GN, Khrenov AV, Loginov AS, et al. (1997) Mechanisms of cycloheximide-induced apoptosis in liver cells. FEBS Letters 416: 113-116.
54. Baskic D, Popovic S, Ristic P, Arsenijevic NN, (2006) Analysis of cycloheximide-induced apoptosis in human leukocytes: fluorescence microscopy using annexin V/propidium iodide versus acridin orange/ethidium bromide. Cell Biology International 30: 924-932.
55. Ringold GM, Dieckmann B, Vannice JL, Trahey M, McCormick F, (1984) Inhibition of protein synthesis stimulates the transcription of human beta-interferon genes in Chinese hamster ovary cells. Proc Natl Acad Sci U S A 81: 3964-3968.
56. Bocci V, Muscettola M, Paulesu L, Grasso G, (1985) The physiological interferon response. V. Antiviral activity present in rat lymph is neutralized by anti-mouse interferon-gamma antibodies. Microbiologica 8: 405-410.
57. Bocci V, Paulesu L, Muscettola M, Viti A, (1985) The physiologic interferon response. VI. Interferon activity in human plasma after a meal and drinking. Lymphokine Res 4: 151-158.
58. De Maeyer-Guignard J, Marcucci F, De Maeyer E, (1988) Identification by in situ hybridization of IFN-beta-producing murine macrophages obtained from high and low interferon producers. Ann Inst Pasteur Virol 139: 51-57.
59. Sato M, Suemori H, Hata N, Asagiri M, Ogasawara K, et al. (2000) Distinct and essential roles of transcription factors IRF-3 and IRF-7 in response to viruses for IFN-alpha/beta gene induction. Immunity 13: 539-548.
60. Lienenklaus S, Cornitescu M, Zietara N, Lyszkiewicz M, Gekara N, et al. (2009) Novel reporter mouse reveals constitutive and inflammatory expression of IFN-beta in vivo. J Immunol 183: 3229-3236.
61. Taniguchi T, Takaoka A, (2001) A weak signal for strong responses: interferon-alpha/beta revisited. Nat Rev Mol Cell Biol 2: 378-386.
62. Cheung CY, Poon LL, Lau AS, Luk W, Lau YL, et al. (2002) Induction of proinflammatory cytokines in human macrophages by influenza A (H5N1) viruses: a mechanism for the unusual severity of human disease? Lancet 360: 1831-1837.
63. Zhu Q, Yang H, Chen W, Cao W, Zhong G, et al. (2008) A naturally occurring deletion in its NS gene contributes to the attenuation of an H5N1 swine influenza virus in chickens. J Virol 82: 220-228.
64. Garcia-Sastre A, (2006) Antiviral response in pandemic influenza viruses. Emerg Infect Dis 12: 44-47.
65. Garcia-Sastre A, Biron CA, (2006) Type 1 interferons and the virus-host relationship: a lesson in detente. Science 312: 879-882.
66. Huprikar J, Rabinowitz S, (1980) A simplified plaque assay for influenza viruses in Madin-Darby kidney (MDCK) cells. J Virol Methods 1: 117-120.
67. Hurd SZ, (1991) Workshop summary and guidelines: investigative use of bronchoscopy. J Allergy Clin immunol 88: 808-814.
68. Oshansky CM, Pickens JA, Bradley KC, Jones LP, Saavedra-Ebner GM, et al. (2011) Avian influenza viruses infect primary human bronchial epithelial cells unconstrained by sialic acid alpha2,3 residues. PLoS ONE 6: e21183.
69. Watanabe A, Tatematsu M, Saeki K, Shibata S, Shime H, et al. (2011) Raftlin is involved in the nucleocapture complex to induce poly(I:C)-mediated TLR3 activation. J Biol Chem 286: 10702-10711.